Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - April 2025

Vendors are growing, and product and service offerings are expanding.

The Hot Market for Cold Chain Services

How artificial intelligence tools are helping to optimize the pharmaceutical transport process.

An AI-Pharma Transport Collaboration

How pharma manufacturers can steadily navigate GTN components and complexities when planning pharmacy benefit reimbursement.

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit

Founder and Principal Consultant at 1st Line Partners.

Articles

Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrity—and ultimately patients.

Welcome to the 'Dark Side'

Videos

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, shares how the development of technology will help bolster the pharma logistics industry. 

The Future of Personalized Medicine

The latest news for pharma industry insiders.

Pharma Pulse 2/7/25: The Impact of AI-Driven Discovery Platforms, Caring for the Caregiver & more

Finding the optimal balance in pharmacy benefit manager reform.


Rebates or Patients?

New engagement approaches can help drive treatment gains in underrepresented communities.


Closing the Health Literacy and Diversity Gaps in Clinical Trials

A survey study of US employers aims to determine whether they prioritize financial or nonfinancial criteria when selecting health plans.

A Further Exploration of Employer Benefits

A look at the actionable steps needed to elicit change.


Popping the Gross-to-Net Bubble, Part II: What Manufacturers Can Do About It

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jim Shehan, chair of the FDA regulatory practice at Lowenstein Sandler, describes what the approach of pharma companies should be amid the latest/pending tariffs imposed on Canada, Mexico, and China, along with their potential impact on the pharma supply chain.

How Tariffs Could Affect Generic Drug Prices and the Global Pharmaceutical Market

Pharma Pulse 2/6/25: The Blue Jacket Fashion Show, Gold Bagging & more

The company cites a decline in sales and excess inventory as the main contributing factors. 

Featured Content

Pharmaceutical Commerce - April 2025

The Hot Market for Cold Chain Services

An AI-Pharma Transport Collaboration

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit